Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer

Nature Genetics

Volumn 48, Issue 7, 2016, Pages 758-767

  McPherson, Andrew ^a,b,c   Roth, Andrew ^a,c   Laks, Emma ^a   Masud, Tehmina ^a,c   Bashashati, Ali ^a   Zhang, Allen W ^a,c,d   Ha, Gavin ^a,c,e,f   Biele, Justina ^a   Yap, Damian ^a   Wan, Adrian ^a   Prentice, Leah M ^a   Khattra, Jaswinder ^a   Smith, Maia A ^a,c   Nielsen, Cydney B ^c   Mullaly, Sarah C ^a   Kalloger, Steve ^a   Karnezis, Anthony ^a   Shumansky, Karey ^a   Siu, Celia ^a   Rosner, Jamie ^a   Chan, Hector Li ^a   Ho, Julie ^a   Melnyk, Nataliya ^a   Senz, Janine ^a   Yang, Winnie ^a   Moore, Richard ^a   Mungall, Andrew J ^a   Marra, Marco A ^a   Bouchard Côté, Alexandre ^c   Gilks, C Blake ^g   Huntsman, David G ^a,c   McAlpine, Jessica N ^c   Aparicio, Samuel ^a,c   Shah, Sohrab P ^a,c   more..

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; NEUROFIBROMIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; RAD51 PROTEIN; RAD51B PROTEIN; RETINOBLASTOMA BINDING PROTEIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; CLADISTICS; CLINICAL ARTICLE; CLINICAL FEATURE; CLONAL EVOLUTION; CLONE; CONVERGENT EVOLUTION; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; HIGH GRADE SEROUS OVARIAN CANCER; HUMAN; HUMAN TISSUE; LOSS OF FUNCTION MUTATION; MUTATIONAL ANALYSIS; OVARY CANCER; PERITONEUM METASTASIS; PHYLOGENY; POLYPHYLY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SEEDING; AGED; CANCER GRADING; CELL CLONE; CYSTADENOCARCINOMA; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN GENOME; METABOLISM; MIDDLE AGED; MUTATION; OVARY TUMOR; PATHOLOGY; PERITONEUM TUMOR; PROCEDURES; SINGLE CELL ANALYSIS; SURVIVAL RATE; TUMOR MICROENVIRONMENT; TUMOR RECURRENCE; UTERINE TUBE TUMOR;

AGED; BIOMARKERS, TUMOR; CLONE CELLS; CYSTADENOCARCINOMA, SEROUS; DISEASE PROGRESSION; FALLOPIAN TUBE NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VARIATION; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PHYLOGENY; SINGLE-CELL ANALYSIS; SURVIVAL RATE; TUMOR MICROENVIRONMENT;

EID: 84968547900     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3573     Document Type: Article

References (27)

1. Ahmed, A. A. et al. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J. Pathol. 221, 49-56 (2010).
2. Patch, A.-M. et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature 521, 489-494 (2015).
3. Bashashati, A. et al. Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. J. Pathol. 231, 21-34 (2013).
4. Ha, G. et al. TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data. Genome Res. 24, 1881-1893 (2014).
5. Schwarz, R. F. et al. Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis. PLoS Med. 12, e1001789 (2015).
6. Jacobs, I. J. et al. Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. J. Natl. Cancer Inst. 84, 1793-1798 (1992).
7. Khalique, L. et al. The clonal evolution of metastases from primary serous epithelial ovarian cancers. Int. J. Cancer 124, 1579-1586 (2009).
8. Lengyel, E. Ovarian cancer development and metastasis. Am. J. Pathol. 177, 1053-1064 (2010).
9. Campbell, P. J. et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109-1113 (2010).
10. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012).
11. Gerlinger, M. et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat. Genet. 46, 225-233 (2014).
12. Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature 520, 353-357 (2015).
13. Eirew, P. et al. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature 518, 422-426 (2015).
14. Gawad, C., Koh, W. & Quake, S. R. Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics. Proc. Natl. Acad. Sci. USA 111, 17947-17952 (2014).
15. Wang, Y. et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 512, 155-160 (2014).
16. Alekseyenko, A. V., Lee, C. J. & Suchard, M. A. Wagner and Dollo: a stochastic duet by composing two parsimonious solos. Syst. Biol. 57, 772-784 (2008).
17. Ryder, R. J. & Nicholls, G. K. Missing data in a stochastic Dollo model for binary trait data, and its application to the dating of Proto-Indo-European. J. R. Stat. Soc. Ser. C Appl. Stat. 60, 71-92 (2011).
18. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013).
19. Blei, D. M., Ng, A. Y. & Jordan, M. I. Latent dirichlet allocation. J. Machine Learning Res. 3, 993-1022 (2003).
20. Bamford, S. et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br. J. Cancer 91, 355-358 (2004).
21. Roth, A. et al. Clonal genotype and population structure inference from single-cell tumor sequencing. Nat. Methods http://dx. doi. org/10. 1038/nmeth. 3867 (2016).
22. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011).
23. Hoogstraat, M. et al. Genomic and transcriptomic plasticity in treatment-naive ovarian cancer. Genome Res. 24, 200-211 (2014).
24. Cooke, S. L. & Brenton, J. D. Evolution of platinum resistance in high-grade serous ovarian cancer. Lancet Oncol. 12, 1169-1174 (2011).
25. Schrader, K. A. et al. Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy. Obstet. Gynecol. 120, 235-240 (2012).
26. McAlpine, J. N. et al. BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma. Mod. Pathol. 25, 740-750 (2012).
27. Roth, A. et al. PyClone: statistical inference of clonal population structure in cancer. Nat. Methods 11, 396-398 (2014).